{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:15:31Z","timestamp":1790129731669,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ogc.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T08:52:05Z","timestamp":1602060725000},"page":"595-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antibiotics for Prophylaxis in the Setting of Preterm Prelabor Rupture of Membranes"],"prefix":"10.1016","volume":"47","author":[{"given":"Sarah","family":"Dotters-Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ogc.2005.03.003","article-title":"Preterm premature rupture of the membranes: current approaches to evaluation and management","volume":"32","author":"Mercer","year":"2005","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ogc.2020.08.005_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.placenta.2016.03.015","article-title":"The physiology of fetal membrane weakening and rupture: Insights gained from the determination of physical properties revisited","volume":"42","author":"Kumar","year":"2016","journal-title":"Placenta"},{"issue":"9","key":"10.1016\/j.ogc.2020.08.005_bib3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/14767050902922581","article-title":"Neonatal outcomes in the setting of preterm premature rupture of membranes complicated by chorioamnionitis","volume":"22","author":"Aziz","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.ogc.2020.08.005_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ajog.2015.06.064","article-title":"Serious maternal complications after early preterm delivery (24-33\u00a0weeks' gestation)","volume":"213","author":"Reddy","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib5","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/AOG.0000000000003700","article-title":"Prelabor rupture of membranes: ACOG practice bulletin, number 217","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.ogc.2020.08.005_bib6","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3109\/14767058.2015.1103729","article-title":"A\u00a0new antibiotic regimen treats and prevents intra-amniotic inflammation\/infection in patients with preterm PROM","volume":"29","author":"Lee","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.ogc.2020.08.005_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/jpm-2014-0249","article-title":"Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques","volume":"43","author":"Romero","year":"2015","journal-title":"J\u00a0Perinat Med"},{"issue":"4 Suppl","key":"10.1016\/j.ogc.2020.08.005_bib8","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ajog.2015.08.040","article-title":"Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.08.005_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/infdis\/157.1.113","article-title":"Intraamniotic infection in low-birth-weight infants","volume":"157","author":"Sperling","year":"1988","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.ogc.2020.08.005_bib10","article-title":"Antibiotics for preterm rupture of membranes","author":"Kenyon","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9646","key":"10.1016\/j.ogc.2020.08.005_bib11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(08)61202-7","article-title":"Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial","volume":"372","author":"Kenyon","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ogc.2020.08.005_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.1997.03550120049032","article-title":"Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","volume":"278","author":"Mercer","year":"1997","journal-title":"JAMA"},{"issue":"9261","key":"10.1016\/j.ogc.2020.08.005_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(00)04233-1","article-title":"Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE collaborative group","volume":"357","author":"Kenyon","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0002-9378(88)80002-4","article-title":"Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study","volume":"159","author":"Amon","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Pt 1","key":"10.1016\/j.ogc.2020.08.005_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0002-9378(96)80049-4","article-title":"Group B streptococcus and preterm premature rupture of membranes: a randomized, double-blind clinical trial of antepartum ampicillin","volume":"175","author":"Grable","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0002-9378(90)91060-P","article-title":"Antibiotic therapy in preterm premature rupture of membranes: a randomized, prospective, double-blind trial","volume":"163","author":"Johnston","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2020.08.005_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0002-9378(94)70220-9","article-title":"A\u00a0prospective, randomized, placebo-controlled trial of penicillin in preterm premature rupture of membranes","volume":"170","author":"Ernest","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9378(92)91336-9","article-title":"Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients","volume":"166","author":"Mercer","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.08.005_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2007-994661","article-title":"Premature rupture of the membranes: effect of penicillin prophylaxis and long-term outcome of the children","volume":"9","author":"Kurki","year":"1992","journal-title":"Am J Perinatol"},{"issue":"4","key":"10.1016\/j.ogc.2020.08.005_bib20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/0002-9378(93)90037-J","article-title":"Double-blind; placebo-controlled trial of piperacillin prophylaxis in preterm membrane rupture","volume":"169","author":"Lockwood","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9378(91)90299-7","article-title":"Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of erythromycin","volume":"165","author":"McGregor","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2020.08.005_bib22","first-page":"759","article-title":"Expectant management of preterm ruptured membranes: effects of antimicrobial therapy","volume":"80","author":"Christmas","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2020.08.005_bib23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1067\/mob.2003.382","article-title":"Antibiotic therapy in preterm premature rupture of membranes: are seven days necessary? a preliminary, randomized clinical trial","volume":"188","author":"Lewis","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1067\/S0002-9378(03)00765-8","article-title":"Duration of antibiotic therapy after preterm premature rupture of fetal membranes","volume":"189","author":"Segel","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/AOG.0000000000000426","article-title":"A\u00a0retrospective comparison of antibiotic regimens for preterm premature rupture of membranes","volume":"124","author":"Pierson","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2020.08.005_bib26","doi-asserted-by":"crossref","first-page":"144.e141","DOI":"10.1016\/j.ajog.2019.03.009","article-title":"Azithromycin vs erythromycin for the management of preterm premature rupture of membranes","volume":"221","author":"Navathe","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"1 Supplement 1","key":"10.1016\/j.ogc.2020.08.005_bib27","first-page":"129","article-title":"The obstetrics and gynecology milestone project","volume":"6","year":"2014","journal-title":"J\u00a0Grad Med Educ"},{"issue":"10017","key":"10.1016\/j.ogc.2020.08.005_bib28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)00724-2","article-title":"Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial","volume":"387","author":"Morris","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ogc.2020.08.005_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/AOG.0000000000002447","article-title":"Immediate delivery compared with expectant management in late preterm prelabor rupture of membranes: an individual participant data meta-analysis","volume":"131","author":"Quist-Nelson","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2007-994310","article-title":"The clinical outcome of preterm premature rupture of membranes in twin versus singleton pregnancies","volume":"13","author":"Bianco","year":"1996","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.ogc.2020.08.005_bib31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0002-9378(11)90783-2","article-title":"Clinical characteristics and outcome of twin gestation complicated by preterm premature rupture of the membranes","volume":"168","author":"Mercer","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2020.08.005_bib32","article-title":"Antibiotics for preterm premature rupture of membranes","author":"Kenyon","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib33","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1055\/s-0036-1587324","article-title":"Prophylactic antibiotics in twin pregnancies complicated by previable preterm premature rupture of membranes","volume":"6","author":"Myrick","year":"2016","journal-title":"AJP Rep"},{"issue":"4","key":"10.1016\/j.ogc.2020.08.005_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/AOG.0000000000002347","article-title":"Obstetric care consensus no. 6 summary: periviable birth","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2020.08.005_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3233\/NPM-16165","article-title":"Use of prophylactic antibiotics in women with previable prelabor rupture of membranes","volume":"10","author":"Dotters-Katz","year":"2017","journal-title":"J\u00a0Neonatal Perinatal Med"},{"issue":"3","key":"10.1016\/j.ogc.2020.08.005_bib36","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/AOG.0000000000002833","article-title":"ACOG practice bulletin no. 199: use of prophylactic antibiotics in labor and delivery","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2020.08.005_bib37","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1055\/s-0039-1683378","article-title":"The effect of non-penicillin antibiotic regimens on neonatal outcomes in preterm premature rupture of membranes","volume":"9","author":"Siegel","year":"2019","journal-title":"AJP Rep"},{"issue":"RR-10","key":"10.1016\/j.ogc.2020.08.005_bib38","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452030070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452030070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:18:04Z","timestamp":1760177884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985452030070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S088985452030070X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2020.08.005","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotics for Prophylaxis in the Setting of Preterm Prelabor Rupture of Membranes","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}